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Abstract
Background: Cancer is one of the leading cause of mortality. Even though efficient drugs are being produced to
treat cancer, conventional medicines are costly and have adverse effects. As a result, alternative treatments are
being tried due to their low cost and little or no adverse effects. Our previous study identified one such alternative
in rice callus suspension culture (RCSC) which was more efficient than Taxol® and Etoposide, in reducing the
viability of human colon and renal cancer cells in culture with minimal or no effect on a normal cell line.
Methods: In this study, we tested the effect of RCSC by studying the dynamics of lactate dehydrogenase (LDH) in
lung cancer cell lines (NCI-H460 and A549), breast cancer cell lines (MDA-MB-231 and MCF-7) and colorectal cancer
cell lines (SW620 and Caco-2) as well as their normal-prototypes. Complementary analysis for evaluating membrane
integrity was performed by estimating LDH release in non-lysed cells and cell viability with WST-1 assay. Fluorescence
microscopy with stains targeting nucleus and cell membrane as well as caspase 3/7 and Annexin V assays
were performed. Real-time quantitative RT-PCR was performed to evaluate expression of 92 genes associated
with molecular mechanisms of cancer in RCSC treated ling cancer cell line, NCI-H460 and its normal
prototype, MRC-5. High performance liquid chromatography (HPLC) was used to collect RCSC fractions, which
were evaluated on NCI-H460 for their anti-cancer activity.
Results: Lower dilutions of RCSC showed maximum reduction in total LDH indicating reduced viability in
majority of the cancer cell lines tested with minimal or no effect on normal cell lines compared to the control.
Complementary analysis based on LDH release in non-lysed cells and WST-1 assay mostly supported total LDH results.
RCSC showed the best effect on the lung non-small carcinoma cell line, NCI-H460. Fluorescence microscopy analyses
suggested apoptosis as the most likely event in NCI-H460 treated with RCSC. Gene expression analysis identified
significant upregulation of cJUN, NF-κB2 and ITGA2B in NCI-H460 which resulted most likely in the arrest of cell cycle
progression and induction of apoptotic process. Further, HPLC-derived RCSC fractions were less effective in reducing
cell viability than whole RCSC suggesting that a holistic approach of using RCSC is a better approach in inhibiting
cancer cell proliferation.
Conclusions: RCSC was found to be an effective anti-cancer agent on cell lines of multiple cancer types with the best
effect on lung cancer cell lines. A possible mechanism for the anticancer activity of RCSC is through induction of
apoptosis as observed in the lung cancer cell line, NCI-H460.
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Background
The incidence of cancer has been reported to increase
with age. Estimated cases reported for lung, breast, and
colorectal cancers are 1.82, 1.67 and 1.36 million, re-
spectively [1]. Among these, lung cancer caused the
most number of deaths at 1.6 million. Cancer incidence
is estimated to increase every year reaching 26 million
new cases and 17 million deaths per year by 2030 [2]. A
diagnostic feature of cancer is uncontrolled cell prolifer-
ation, which is normally maintained by mutational
events that regulate various signaling and metabolic
pathways. Transformation of a normal cell to tumor cell
requires continuous growth signals, resistance to apop-
tosis, the ability of angiogenesis and finally tissue inva-
sive and migratory capability. Eradication of cancer
seems inevitable since the core cause of its pathogenesis
is the rapidly changing cell machinery. The reason behind
these mutations is different from one cell to another and
one patient to another. With the ever-increasing incidence
of cancer, the need for better and efficient drugs is a target
of most cancer researchers. Since cancer cells tend to use
their normal signaling and metabolic machinery to prolif-
erate and progress, it is difficult to specifically target can-
cer cells. The adverse effects due to the targeting of
normal cells surrounding cancer cells render these drugs
ineffective. Identifying compounds specifically targeting
cancer cells have therefore been the main focus of re-
searchers over the last two decades.
Plants have been a direct/indirect source of medicine
in the past and their medicinal properties continue to be
investigated and exploited all over the world [3–7]. The
World Health Organization (WHO) has estimated that
about 80 % of the human population rely on herbal
drugs than on conventional synthetic drugs [8]. The bio-
active components of plants have been documented as
potential anti-cancer agents. This is supported by the
fact that about 60 % of the prescribed anti-cancer drugs
are either synthetic or semi-synthetic derivatives of plant
metabolites. These include paclitaxel derived from Pa-
cific yew, vinca alkaloids like vincristine and vinblastine
from Madagascar periwinkle, and etoposide from Podo-
phyllum species. Despite advances in the development of
synthetic oncogenic drugs, researchers are continually
trying to identify plant-derived metabolites that effect-
ively target cancer cells, have high efficacy with min-
imal/no adverse effects, non-toxic to healthy tissues and
systems, readily available, and affordable. Indeed, some
plant metabolites have been reported in targeting can-
cerous cells with minimal or no effect on normal cells.
For example, extracts of Kalanchoe tubiflora showed cell
cycle arrest and senescence-inducing effect against vari-
ous cancer cell lines [9] and A. monosperma [10] showed
anticancer effects against various hematological and
solid tumor cell lines by inducing apoptosis. They
comparatively showed minimal or no effects on normal
healthy cell cultures. These effects are therefore consid-
ered better compared to the toxicity of drugs like tax-
anes and vinca alkaloids have on normal cell lines.
Plant callus has been a new target of research because
they harbor metabolites with significant health benefits.
Callus is a mass of somatic undifferentiated totipotent
cells. Callus extracts were found to perform better than
extracts from plant parts against various diseases. For
example, Aegele marmelos whole callus extract lowered
blood sugar more efficiently than the leaf extract [11].
The overall synergistic effects of various compounds in
the callus extract could be the possible reason for this
observation. Rice callus suspension culture (RCSC) was
shown to harbor anticancer activity with 95 % and 87 %
reduction in cell viability of a renal cancer cell line
(RXF-393) and a colon cancer cell line (SW620), re-
spectively, in a dose and time-dependent manner,
with minimal inhibition of normal lung fibroblast cell
line (MRC-5) [12]. However, only once cell line for
each of the two cancer types was used and the corre-
sponding normal cell lines for renal and colon cancer
were not evaluated in the above report.
The most common cancer types in the United States
include lung, breast, and colorectal cancers (https://
www.cancer.gov/about-cancer/understanding/statistics).
In the current study, the anticancer activity of different di-
lutions of RCSC was tested on these three cancer types
using two human cell lines for each cancer type and corre-
sponding normal cell lines. The cancer type that showed
the best response to RCSC treatment was characterized
with reference to apoptotic markers, and the expression of
specific cancer-related genes.
Methods
Rice callus suspension culture (RCSC) and plant medium
(PM) preparation
Liquid plant medium (PM) was prepared first by dissolv-
ing Murashige and Skoog (MS) media (PhytoTechnology
Lab) in deionized water supplemented with proline,
casamino acids and sucrose and autoclaved for 20 min
at 125 °C. After cooling, it was further supplemented
with 2,4D (2,4 dichlorophenoxyacetic acid) and Chu’s
N6 vitamins (PhytoTechnology Lab). RCSC was pre-
pared as described earlier [12]. Briefly, rice callus was
produced from seeds grown in sterile solid plant
medium followed by their transfer to sterile liquid plant
medium. The calli were allowed to grow and exude
compounds in the liquid medium for three weeks. At
the end of three weeks, UV absorbance between 240 nm
and 300 nm was measured using Nanodrop. RCSC was
then centrifuged at 10,000 rpm for 10 min at 4 °C to re-
move particulate matter and cell debris. The clear super-
natant was filter-sterilized and aliquoted aseptically into
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50 mL sterile culture tubes and stored at −20 °C for
further use.
Human cancer cell lines, culturing, passaging and seeding
The cell lines selected for this study were human lung
cancer cell lines (NCI-H460 and A549), breast cancer
cell lines (MCF7 and MDA-MB-231), and colorectal
cancer cell lines (SW620 and Caco-2). Normal proto-
types used as control were lung fibroblast (MRC-5), hu-
man mammary epithelial cell line (HMEC) and normal
colon mucosal cell line (NCM356). All cell lines, except
NCM356, were obtained from ATCC (American Type
for Culture Collection). NCM356 was licensed from
INCELL Corporation (San Antonio, TX). Cell culturing
media was obtained from ATCC or INCELL.
The cell lines were cultured in their respective media,
namely, Dulbecco’s minimal essential medium (DMEM)
for MDA-MB 231, Eagle’s minimum essential medium
(EMEM) for MCF-7, Caco-2, and MRC-5), Roswell Park
Memorial Institute (RPMI-1640) for NCI-H460 and
SW620, M3:BaseA culture media for NCM-356, F-12 K
for A549, and mammary epithelial cell base medium for
HMEC. Media was supplemented with Fetal Bovine
Serum (FBS) to a final concentration of 10 % except for
Caco-2 where it was 20 % as per manufacturers’ specifica-
tion. Penicillin, streptomycin and amphotericin solution
(ATCC) was added to the media diluted to 1000-fold
(final). The cells were stored in liquid nitrogen vapor
phase until further use. For cell culturing, corresponding
vials were thawed by immersing them in a water bath at
37 °C for no more than 10 s. The cells were then immedi-
ately transferred to 100 × 20 mm sterile culture dish con-
taining 10 mL of appropriate culture medium in the
sterile cell culture hood. The plate(s) was then incubated
at 37 °C at 5 % CO2 and 95 % relative humidity. Once the
cells reached 80–90 % confluence, they were trypsinized
with trypsin-EDTA (Hyclone) according to the manufac-
turer’s cell culture protocol. Briefly, first used cell culture
medium was discarded and washed with 2 mL of trypsin-
EDTA to remove any traces of medium. Then 3 mL of
trypsin-EDTA was added and left for 5–10 min until the
cell monolayer detached from the culture plate. Then
trypsin was diluted with 7 mL of respective cell media.
After trypsinization the cells were passaged, seeded or
frozen depending on the experimental requirements.
Cell counting and seeding protocol
Cells were counted in a hemocytometer using trypan
blue stain. First, the cells were diluted in 1:20 ratio with
cell culture medium. They were further diluted with try-
pan blue by adding 10 μL of stain to 50 μL of cells and
counted in a hemocytometer. Number of cells per mL was
calculated by using the formula: No. of cells/mL = (x) *
(20) * (1.2) * 104 where, x = average no. of cells in 4
squares, 20 = first dilution factor with cells and medium,
1.2 = second dilution factor with trypan blue. After each
cell count, the volume of cells and medium needed for
each experiment were taken and cells were seeded in each
well of the 96 well flat bottom dark plate and incubated in
a humidified 5 % CO2 incubator at 37 °C for 24 h before
further experimental procedure.
Cell freezing protocol
For freezing, the cell monolayer were first detached
using trypsin-EDTA as mentioned above and transferred
into 15 ml or 50 ml conical tube and centrifuged at
1100 rpm except for NCM-356 cells, which were centri-
fuged at 2000 rpm for 10 min. The cell pellet was sus-
pended in freezing medium (10 % DMSO). Cells were
stored first in −20 °C for 24 h followed by −80 °C for the
next 24 h before storing it in liquid nitrogen.
Treatment of cell lines with RCSC and PM
After the respective cell lines reached the desired conflu-
ence, they were seeded in a 96 well plate with cell dens-
ities of 10,000 cells/mL and 25,000 cells/mL in 100 μL
volume. After 24 h of incubation, cells were treated in
triplicate with different dilutions of filter sterilized RCSC
or plant medium (PM). Five 2-fold serial dilutions (1:5,
1:10, 1:20, 1:40, and 1:80) of RCSC, corresponding to
0.25, 0.5, 1, 2 and 4 mg/mL of rice callus tissue were
used to treat the cells for 24, 48, 72, and 96 h. In
addition, three working concentrations of Taxol namely,
10−5 M, 10−6 M, 10−7 M, corresponding to 8.56, 0.856
and 0.0856 μg/mL were included as a positive control.
Treatment with 0.05 % DMSO was included as a nega-
tive control. Stock solution (250 mM) of Taxol® was
made in 100 % DMSO. At the end of the treatment
period, cell proliferation assay, WST-1 and cytotoxicity
assay (LDH assay) were performed. Cells were analyzed
for morphological changes using an inverted light micro-
scope at 5×, 10× and 40× magnifications.
Cell viability assay
Cell viability assay was performed using pre-mixed
WST-1 cell proliferation assay (Takara). WST-1 reagent
contains a tetrazolium salt that is cleaved by mitochon-
drial reductase enzymes of a viable cell to produce yel-
low to orange colored formazan dye. Formazan is
known to show an absorbance at 440 nm. The intensity
of formazan dye depends on the number of viable cells
or metabolically active cells. After each treatment period,
10 μL of WST-1 reagent was added to each well and
plates were incubated at 37 °C at 5 % CO2 for 2 h. Ab-
sorbance was measured in a Multiskan plate reader
(Thermo Scientific) at 440 nm. Percent decrease in cell
viability was calculated from the absorbance of negative
control or untreated cells as per the kit protocol. A two-
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sample t-test was performed using the function in
Microsoft Excel to determine the statistical significance
of the data at p < 0.05 and p < 0.01.
Cytotoxicity assay
Cytotoxicity assay was performed using CytoTox 96
non-radioactive cytotoxicity assay kit (Promega). The
total LDH (lysis) and the LDH released (non-lysis) from
the cell due to changes in the cell membrane integrity
were measured using this kit. The assay reagent contains
tetrazolium salts that get reduced by the LDH of the cell
to produce reddish formazan product, which is mea-
sured at 490 nm. The Total LDH content of the cell was
measured by lysing the cell followed by the addition of a
substrate buffer and quantification of red colored forma-
zan produced by the reaction using Multiskan plate
reader. The percentage of total LDH content and LDH
released was measured as per the kit protocol. Statistical
analysis was performed as described above for cell viabil-
ity assay.
Fluorescence microscopy
Cells were seeded into 96 well plates at a density of
25,000 cells/mL and allowed to acclimate for 24 h before
treatment. The cells were then treated with selected 1:5
and 1:40 dilutions of RCSC and plant medium. Taxol
and DMSO treatments were also included as positive
and negative controls, respectively. Cells were subjected
to treatment for 24 h and 72 h. At the end of the treat-
ment period, the cells were stained with NucBlue live
cell stain, Cell Mask plasma membrane stain (green),
Alexa Flour 488 annexin V/dead cell apoptosis kit with
Alexa® Fluor 488 annexin V and PI, and Caspase 3/7
stain (Life Technologies). NucBlue live cell stain is a
Hoechst 33342 stain, which is highly cell permeable and
binds DNA emitting fluorescence observed at 365 nm
with an emission maximum of 460 nm. Cell mask PM
stain is a lyphophilic stain that efficiently stains live
membrane emitting fluorescence at 522 nm. NucBlue
stain and Cell mask PM stain were used together to stain
each seeded wells according to manufacturer’s protocol.
AnnexinV binds to the externalized phosphatidyl serine
(PS) staining it green and denotes the early stage of
apoptosis. Propidium iodide (PI) stain is cell imper-
meant, which enters the cell only when the cell mem-
brane is disrupted and stains the chromatin red
indicating the loss of membrane integrity due to the
cytotoxic effect of agents or due to ongoing necrosis
process. Both Annexin and PI stain were used together
according to protocol instructions. Caspase 3/7 stain is a
cell-permeant DNA binding stain that emits green fluor-
escence when caspases 3 and 7 are activated.
Fluorescence emitted from NucBlue, AnnexinV and PI
stains was observed at 365 nm with a Zeiss fluorescence
microscope. Plasma membrane and caspase 3/7 activity
detecting stains were observed at 470 nm. All the sam-
ples were observed at 10× and 20× magnifications.
Image J software was used to quantify fluorescence by
calculating corrected total cell fluorescence (CTCF)
(http://imagej.nih.gov/ij/index.html).
Scanning electron microscopic analysis
Preparation of SW620 for SEM was done using standard
methods [13, 14] with some modifications. The colon
cancer cells (5000 cells/mL) were grown on a sterile
cover slip placed at the bottom of a polyvinyl coated
petri dish. DMEM growth medium was supplemented
with filter sterilized 1:5 RCSC dilution. After 96 h of
treatment at 37 °C in 5 % CO2, the cover slips were re-
moved, and the adherent cells were fixed using 1 % glu-
taraldehyde in 0.15 M phosphate buffer (pH 7.3) and
incubated for 12 h. Cells were again washed 3–4 times
in phosphate buffer and post fixed in 1 % osmium tetra-
oxide containing 0.15 % phosphate buffer (pH 7.3) for
1 h. Incubated cells were washed with buffer for 3–4
times followed by washes with sterile distilled water. The
cells were then dehydrated in a series of graded ice cold
alcohol (50 %, 80 %, 95 %, and 100 %), soaking the cells
in each solution for 1 min. Once the dehydration was
achieved, they were transferred to 100 % ethanol at
room temperature and incubated for 20–30 min. The
last step was repeated twice. The cells on cover slips
were washed with acetone thrice and air dried at 28 °C.
The cover slip with processed cells were then cut into
small squares (5 × 5 mm) and glued onto polished
aluminum stubs. The stubs were sputter coated with plat-
inum nanoparticles 100A thick and observed under SEM.
HPLC fractionation
RCSC and plant medium were fractionated using high
performance liquid chromatography (HPLC). Fifty mL
each of filter sterilized RCSC (corresponds to 20 mg
callus/mL) and plant medium were lyophilized and dis-
solved in 2 mL of sterile deionized water to a final con-
centration of 500 mg/mL. Hundred microliters of each
sample was injected in a C18 reverse phase column
(Varian) and fractionation was performed using a photo
diode array detector (Agilent Technologies). The total
run time was 65 min. Compounds were separated in a
binary gradient of 5 % acetic acid (solvent A) and 50 %
acetonitrile (Solvent B). A total of eight fractions with
retention time 2 min to 31.7 min were collected. Four
fractions of RCSC that contained significant peaks on
the chromatogram and were absent from the plant
medium control were chosen for further analysis. The
fractions collected were calculated as a percentage of the
total area of peaks at 254 nm.
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Treatment with HPLC fractions and LDH assay
Cells were seeded in a 96 well plate at a density of
25,000 cells/mL and incubated for 24 h at 37 °C with
5 % CO2. After 24 h, cells were treated with three 4-fold
serial dilutions (1:10, 1:40, and 1:160) of RCSC fractions
as well as plant medium fractions. LDH assay measuring
total LDH was carried out at four time points, namely,
24 h, 48 h, 72 h, and 96 h. The effects of selected HPLC
fractions were compared with the same dilutions (1:10,
1:40; 1:160) of whole RCSC and plant medium at the
four time points.
Gene expression assay
For gene expression analysis, cells were first grown in
their respective media until confluency, seeded in 6-well
plates at a density of 25,000 cells/mL and treated with
1:5 and 1:40 dilutions of RCSC. The same dilutions for
plant medium were used as negative control. Treatments
were carried out for 24 h and 72 h. Total RNA was iso-
lated from these samples using RNAeasy Plus Mini kit
(Qiagen) according to manufacturer’s instructions. 25 ng
of total RNA was used to make cDNA using SuperScript
VILO Master Mix (Life Technologies). Quantitative RT-
PCR was performed using GADPH and 18S TaqMan®
probes and primers and TaqMan® Universal Master Mix
and run on StepOnePlus Real-Time PCR System (Ap-
plied Biosystems). Three technical replicates and three
biological replicates were used for each sample. The
samples showing constituent expression in both GADPH
and 18S were chosen for qPCR with TaqMan® Array 96
well fast plate (Applied Biosystems). These TaqMan®
plates contain primers and TaqMan® probes for PCR
amplification of 92 genes associated with molecular
mechanisms of cancer and four endogenous control
genes (GADPH, HPRT1 GUSB, and 18S rRNA). The
plate was used to evaluate the relative expression
changes of various cancer-related genes in cell lines
treated with 1:5 and 1:40 dilution of RCSC for 24 h and
72 h. Fold changes in gene expression were calculated
using the Data Assist software (Applied Biosystems).
Results
RCSC affected cell proliferation and viability in a time-
and dose-dependent manner. However, its effectiveness
is strongly influenced by the type of cancer cell line
used. In general, RCSC’s anti-proliferative effect was
most pronounced after 72 or 96 h treatment. Treated
cancer cells were found to be non-proliferative under an
inverted light microscope, as there was no change in the
cell density compared to the untreated control, which
proliferated and grew in number crowding the culture
plate at 96 h. Characteristic changes in the morphology
of cancer cells were observed when compared to their
corresponding negative and plant medium controls with
a dramatic reduction in cell size and increased granula-
tion as observed in NCI-H460 after 96 h treatment. The
presence of secondary metabolites in RCSC are likely to
be responsible for their anticancer effect.
Different cancer types showed differential responses
when treated with RCSC
RCSC treatment showed pronounced effect on metastatic
colon cancer cell line as compared to non-metastatic colon
cancer cell line
SW620 is derived from lymph node metastasis cells
whereas Caco-2 is derived from colon epithelial cells
(non-metastatic) [15]. Initial experiments with SW620
were carried out using two cell densities: 10,000 and
25,000 cells/mL. SW620 was more responsive to RCSC
treatment at higher cell density. Lower dilutions (1:5 to
1:20) of RCSC significantly reduced total LDH in SW620
at a cell density of 25,000 cells/mL starting at 24 h (Add-
itional file 1: Figure S1). The best effect was observed
with 1:5 dilution (4 mg/mL) of RCSC, which reduced
LDH by >90 % compared to the control after 96 h. The
percentage reduction of LDH decreased with increase in
dilutions of RCSC. RCSC effects were better than Taxol®
which showed only 30–50 % reduction of LDH at 96 h.
Caco-2, the other cancer cell line did not show signifi-
cant effect with most RCSC dilutions. Significant de-
crease in total LDH in normal colon cell line, NCM-356,
was observed mostly at 72 h and 96 h, which was less
than the effect of Taxol®. Scanning electron microscopy
analysis of RCSC 1:5 treated SW620 showed reduced cell
number, morphology and increased adhesiveness sug-
gesting apoptosis (Fig. 1). These results suggest that
lower dilutions (1:5 to 1:20) of RCSC would be better for
further testing to treat colon cancer with minimal effect
on normal mucosal cells.
RCSC showed significant effect on the membrane in-
tegrity of SW620 cells with leakage of LDH starting at
48 h. Cell density of 25,000 cells/mL showed the best re-
sults with 1:40 dilution (0.5 mg/mL) of RCSC showing
maximum release of LDH at 72 h (Additional file 2:
Figure S2). In Caco-2, lower dilutions of RCSC
showed better results compared to higher dilutions.
However, LDH release was less in Caco-2 cell line.
No significant effect of RCSC on membrane integrity
of the normal colon mucosal cell, NCM 356 was observed,
which augurs well for the use of RCSC on animal model
with the final goal to treat colon cancer.
WST-1 assay measures the metabolic viability of the
cell through the reduction of tetrazolium salts by various
mitochondrial reductases including LDH, which is a cru-
cial metabolic enzyme in a cancer cell. RCSC treated
SW620 showed a highly significant reduction in cell via-
bility at 96 h (Additional file 3: Figure S3). In compari-
son, Taxol® reduced cell viability to a lesser extent than
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RCSC. In Caco-2 and NCM 356, a significant reduction
was not observed at all RCSC dilutions and all time
points tested.
Hormone independent breast cancer cell line responded
better to RCSC treatment compared to hormone dependent
breast cancer cell line
RCSC at 1:5 dilution showed the best effect in the hor-
mone independent breast cancer cell line, MDA-MB 231
but other lower dilutions (1:10 and 1:20) were also very
effective (Additional file 4: Figure S4). Taxol® was less ef-
fective than RCSC at 72 h and 96 h when compared to
most RCSC dilutions. The effect of RCSC was more pro-
found in 25,000 cells/mL compared 10,000 cells/mL of
MDA-MB-231. The second breast cancer cell line,
MCF-7, which is hormone dependent did not show a
significant reduction in total LDH with RCSC treatment.
Overall, MDA-MB-231 showed better response to RCSC
than MCF-7. RCSC did not reduce the total LDH of the
normal breast epithelial cell line, HMEC.
RCSC showed a significant effect in disrupting mem-
brane integrity of the breast cancer cell line, MDA-MB-
231 with higher dilutions of RCSC at 72 h (Additional
file 5: Figure S5). The effect was comparatively less in
MCF-7. RCSC also reduced the membrane integrity of
normal breast epithelial cells (HMEC) with a significant
release of LDH at all dilutions and treatment points
(Additional file 6: Figure S6). LDH release gradually in-
creased from 24 to 48 h with 221 % release of LDH in
1:5 dilution RCSC treatment followed by a decrease at
72 h and 96 h compared to 48 h. From these observa-
tions, RCSC had some effect in hampering the mem-
brane integrity of MDA-MB-231 and MCF-7. However,
a significant detrimental effect on the membranes of
normal breast cells makes RCSC inefficient in treating
breast cancer.
RCSC reduced cell viability based on WST-1 assay in
MDA-MB-231 with lower RCSC dilutions showing max-
imum effect at 72 h and 96 h with 1:5 to 1:20 dilutions
(Additional file 7: Figure S7). Effect of Taxol® was com-
paratively less than RCSC. RCSC did not show signifi-
cant effect on the cell viability of MCF-7 and HMEC.
Lung cancer cell lines showed the best response to RCSC
treatment
RCSC significantly decreased LDH levels in NCI-H460
(non-small lung cancer cell line) and A549 cell line.
RCSC effect on lung cancer cell lines was superior to the
effect observed on colon and breast cancer cell lines.
Lower dilutions of RCSC showed a better effect in redu-
cing LDH than higher dilutions in NCI-H460 (Fig. 2).
RCSC showed a significant effect at all treatment points
and most dilutions of more than 95 % reduction in LDH
with 1:5 to 1:80 dilution at 96 h in 25,000 cells/mL. On
Fig. 1 Scanning electron microscopic analysis of the colon cancer cell line (SW620) grown for 96 h with (a) no treatment (negative control) and
(b) treated with 1:5 dilution of rice callus culture. Higher magnifications of the colon cancer cell line with (c) no treatment and (d and e) treated
with rice callus culture
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the other hand, A549 showed a better response at lower cell
density (10,000 cells/mL) with lower dilutions (1:5, 1:10 and
1:20) of RCSC at 72 h and 96 h showing good results with
a reduction in LDH levels reaching more than 95 % at 96 h
with 1:5 dilution (Fig. 3). Both the lung cancer cell lines
showed best effect at 1:5 dilution at 96 h. Effect of RCSC
on NCI-H460 was better than Taxol® whereas its effect was
comparable to Taxol® in A549 cell line. In normal lung
fibroblast cell line, MRC-5, lower dilutions (1:5, 1:10 and
1:20) of RCSC showed significant reduction in LDH at 72 h
at higher cell density (Additional file 8: Figure S8). Higher
dilutions like 1:40 and 1:80 of RCSC showed less effect on
MRC-5 whereas comparatively Taxol® showed more effect.
These results showed less toxic effect of RCSC than cancer
drugs such as Taxol®.
Significant release of LDH due to loss of membrane
integrity in treated NCI-H460 started at 24 h. The per-
centage of LDH released was the highest in RCSC 1:80
dilution treated sample in comparison to plant medium
control (Fig. 4). The LDH released by Taxol® at all time
points was lower than the highest release by RCSC
treated sample. The membrane integrity was affected in
A549 (25,000 cells/mL) on treatment with RCSC with
maximum LDH release of 188 % at RCSC 1:10 dilution
at 72 h. At 96 h, both NCI-H460 (147 %) and A549
(113 %) released less LDH compared to 72 h probably
because of less total LDH content of the cell at 96 h as
described earlier. The effect of RCSC on both NCI-H460
and A549 at lower cell density was less pronounced
compared to their higher cell density. RCSC had no ef-
fect in disintegrating the membrane integrity of normal
lung fibroblast MRC-5 at any dilution, time point and
cell density. Lung cancer cell lines showed a better effect
on disintegrating the membrane with the highest release
of LDH (250 %) compared to colon and breast cancer
cell lines. In conclusion, RCSC showed a superior effect
on the lung cancer cell line, NCI-H460. It is likely that
RCSC will be effective in treating lung cancer when a
higher dilution like 1:40 or 1:80 is used where the reduc-
tion of LDH at higher cell density was calculated to be
73 % in NCI-H460 and 17 % in A549 at 48 h and the ef-
fect on MRC-5 was minimal.
RCSC hampered the metabolic capacity of NCI-H460
better than colon and breast cancer cell lines. RCSC
effect on cell viability started at 24 h reaching maximal
decrease (~95 %) with all RCSC dilutions at 96 h based
on WST-1 assay (Fig. 5). Effect of Taxol® was compara-
tively lower than RCSC treatment at any time point and
dilution. In A549, the effect of RCSC was less compared
to NCI- H460. Cell viability in A549 was significantly re-
duced starting at 72 h and showed the best effect after
96 h at 1:5 and 1:10 RCSC dilutions (Additional file 9:
Fig. 2 Total LDH of the lung cancer cell line, NCI-H460 treated with Rice Callus Suspension Culture (RCSC). Total LDH of NCI-H460 treated with
different dilutions of rice callus suspension culture for (a) 24 h, (b) 48 h, (c) 72 h, and (d) 96 h. The x-axis shows five dilutions of plant media (PM),
rice callus suspension culture media (CM) and three concentrations of Taxol®. The y-axis shows average absorbance at 490 nm for LDH assay. Error
bars represent standard deviation. Statistically significant effect of different dilutions of CM is indicated by *p < 0.05 and **p < 0.01. Control represents
untreated cell line and Med represents media without cells. Cell density of 25,000 cells/mL was used
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Figure S9). Higher dilutions (1:20–1:80) did not show
any effect on A549. Effects of Taxol® on A549 were less
pronounced than RCSC treatment. In MRC-5, most
RCSC dilutions and time points tested, did not show a
significant reduction in cell viability.
It is evident that the lung cancer cell line, NCI-H460
was responding better to RCSC when compared to other
tested cancer cell lines. To make an efficient anti-cancer
agent, it is important to focus on minimal effect on normal
cells. According to our observations, with reference to the
lung cancer cell line, higher RCSC dilutions like 1:40 and
1:80 (i.e. 0.5 mg/mL and 0.25 mg/mL) showed less effect in
lung fibroblast whereas in breast cancer 1:5 dilution (i.e.
4 mg/mL) of RCSC is better for treating breast cancer cell
line since it showed minimal effect on human mammary
epithelial cell, HMEC. In colon cancer, consistent effect of
RCSC was measured at lower dilutions in SW620 with
minimal or no effect on the normal colon mucosal cells
and non-metastatic cancer cell line, Caco-2. In all of the
above experiments, DMSO control (negative control)
showed no effect on any of the cell lines (data not shown).
RCSC treatment induced apoptosis in lung and colon
cancer cell lines
Lung cancer cell line NCI-H460, which showed the best
response with RCSC was chosen to further investigate
the cellular and morphological changes in RCSC 1:5 and
1:40 dilution treated samples for 24 h and 72 h. RCSC
treated NCI-H460 showed varying degrees of staining
with signs of apoptotic changes. At 24 h, NCI-H460
treated with 1:5 dilution of RCSC showed clear signs of
early stages of apoptosis process with nuclear blebbing
and beginning of chromatin fragmentation in some cells
(Additional file 10: Figure S10), which was accompanied
by an increase in total fluorescence signal. On the other
hand, PM stain showed unequal staining of cell mem-
brane in RCSC 1:5 dilution treated NCI-H460 at 24 h
and 72 h suggestive of loss of membrane structure,
which also correlated with LDH release at that time
point. Cell membrane in NCI-H460 was observed to be
disintegrated in 1:40 dilution RCSC treatment at 72 h.
NucBlue staining was also performed on 25,000 cell
density of MRC-5 treated with 1:5 and 1:40 dilution of
RCSC. No significant changes in the nucleus or chroma-
tin were observed. On the other hand, the colon cancer
cell line, SW620, which gave good biochemical assay re-
sults with RCSC, showed some nuclear condensation
and blebbing with 1:5 and 1:40 dilution RCSC for 72 h
whereas PM stain showed undefined cell membrane with
1:5 dilution RCSC and well-defined cell membrane
at 1:40 dilution RCSC treated sample and control
(Additional file 11: Figure S11).
Fig. 3 Total LDH of the lung cancer cell line, A-549 treated with RCSC. Total LDH of A-549 treated with different dilutions of rice callus suspension
culture for (a) 24 h, (b) 48 h, (c) 72 h, and (d) 96 h. The x-axis shows five dilutions of plant media (PM), rice callus suspension culture media (CM)
and three concentrations of Taxol®. Cell density used was 10,000 cells/mL. Labeling and statistical significance are as described for Fig. 1
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NCI-H460 showed positive staining with annexin V
and PI stain with 1:5 dilution RCSC at 24 h and 72 h
compared to the control suggestive of late stage of apop-
tosis (Fig. 6). The cells showed positive PI stain due to
RCSC affecting the membrane integrity as described
earlier. RCSC 1:40 dilution showed less number of cells
showing positive annexin V stain compared to 1:5 dilu-
tion of RCSC. Apoptosis was also observed in untreated
cells (control) to a less extent suggesting that normal cell
death mechanism was taking place.
Treatment of SW620 with RCSC 1:5 and 1:40 dilutions
for 24 h were positive for PI staining but stained green
(annexin V+) at 72 h suggestive of early stage of apop-
tosis process taking place (Additional file 12: Figure
S12). In comparison to NCI-H460, both the stains were
observed to be less in SW620. Based on annexinV and
PI staining, it can be concluded that RCSC had signifi-
cant effect on NCI-H460 at 24 h showing signs of late
apoptosis whereas the effect on SW620 was observed
later at 72 h.
Positive Caspase 3,7 activation was observed in both
RCSC 1:5 and 1:40 dilution treated NCI-H460 at 24 h
and 72 h (Fig. 7). Caspase activation was higher in 1:5
RCSC dilution treatment at 24 h compared to 72 h
whereas 1:40 RCSC dilution treatment at 72 h showed
higher fluorescence suggestive of ongoing apoptosis
process. The corresponding cells demised at 1:5 RCSC
dilution treatment at 72 h as observed in WST-1 and
LDH assays. These observations were supported by
fluorescence intensity based on Image J data (Additional
file 13: Figure S13 and Additional file 14: Figure S14).
RCSC treatment altered expression of genes involved in
apoptotic pathways
Changes in expression of 92 genes involved in molecular
mechanisms of cancer were investigated in NCI-H460
treated with RCSC to help us identify pathways that may
be involved in maintaining its anticancer activity. Grad-
ual increase in expression of cJUN, a proto-oncogene
was observed from 24 h to 72 h with the highest expres-
sion of 61-fold upregulation in 1:40 RCSC dilution
treated sample compared to the untreated control and
negative control (Fig. 8a). CDKN1A, a gene, which codes
for a cyclin-dependent kinase inhibitor, was upregulated
2.5 fold compared to the control. Genes downregulated
compared to controls at 24 h on treatment with 1:5
RCSC dilution include insulin-like growth factor (IGF1)
(10 fold), CyclinD3 (CCND3) (8 fold), E2 transcription
factor 1 (E2F1) (8 fold), collagen type1 alpha 1
(COL1A1) (5 fold), and cyclin dependent kinase (CDK)
(2.5 fold) (Additional file 15: Figure S15). FASLG gene
was found to be 14-fold upregulated in 1:5 dilution
RCSC treatment after 72 h. Nuclear Factor of Kappa
light polypeptide gene enhancer in B-cells 2 (NF-κB2)
Fig. 4 LDH released from the lung cancer cell line, NCI-H460 treated with RCSC. Release of LDH due to loss of membrane integrity of NCI-H460
treated with different dilutions of rice callus suspension culture for (a) 24 h, (b) 48 h, (c) 72 h, and (d) 96 h. Cell density used, labeling and statistical
significance are as described for Fig. 1
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Fig. 6 Annexin and propidium iodide (PI) staining of NCI-H460 treated with RCSC. (a) Control (untreated) at 24 h, (b) 1:5 dilution RCSC treated
NCI-H460 at 24 h, (a’) Control at 72 h, (b’) 1:5 RCSC treated NCI-H460 at 72 h. NCI-H460 was labeled with Annexin and PI stain and observed at
365 nm (20× magnification)
Fig. 5 Cell viability of the lung cancer cell line, NCI-H460 treated with RCSC. Reduction of cell viability of NCI-H460 treated with different dilutions
of RCSC for (a) 24 h, (b) 48 h, (c) 72 h, and (d) 96 h. The y-axis shows average absorbance at 440 nm for WST-1 assay. Cell density used, other labeling
and statistical significance are as described for Fig. 1
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gene was 2 fold and 30 fold upregulated in 1:5 and 1:40
RCSC dilution treated samples, respectively, at 72 h.
Integrin α2 β (ITGA2B) and Integrin β3 (ITGB3) were
upregulated 7 fold and 31 fold, respectively. Gene ex-
pression analysis of MRC-5 treated with 1:40 dilution
RCSC for 72 h was performed to compare it with
NCI-H460. No changes in gene expression were ob-
served in MRC-5 compared to those observed in
NCI-H460 suggesting that 1:40 dilution RCSC has no
deleterious effects on MRC-5 (Fig. 8b).
HPLC fractions of RCSC showed lower anti-cancer activity
compared to whole RCSC
Lung cancer cell line, NCI-H460, which showed the best
response to RCSC, was chosen to investigate the effects
of four HPLC fractions of RCSC and plant medium. The
fractions collected were calculated as a percentage of the
total area of peaks at 254 nm. The selected fractions,
1, 2, 3 and 5 had 6.5 %, 37 %, 4 % and 6 % of the
total peak area, respectively. The corresponding frac-
tions were collected from plant medium and used as
control (Additional file 16: Figure S16). No significant
reduction of LDH was observed in the fraction
treated samples compared to the whole RCSC treat-
ment. Only 1:160 dilution of HPLC fraction 5 treated
NCI-H460 (72 h) showed some reduction in total
LDH (Additional file 17: Figure S17).
Discussion
Cancer results from activation of oncogenes and/or sup-
pression of tumor suppressor genes leading to important
alterations in several signaling and metabolic pathways
that are advantageous to cancer cell proliferation, sur-
vival, and progression. Altered metabolic pathways are
very crucial for cancer cell proliferation and progression.
Therefore, targeting metabolic pathways serves as a use-
ful therapeutic strategy. Various plant extracts have been
successful in altering the metabolic pathways resulting
in the inhibition in cancer growth and progression. Our
previous study showed that RCSC treatment resulted in
significant reduction in cell viability in a single cell line
of colon and renal cancer based on Crystal Violet assay
[12]. In the present study, RCSC treatment showed a
significant reduction in total LDH in cancer cells in a
dose and time-dependent manner. LDH is a crucial cyto-
solic enzyme in cancer’s altered metabolism that is
Fig. 7 Caspase 3/7 staining of NCI-H460 treated with RCSC. (a) Control (untreated NCI-H460) at 24 h. (b) RCSC 1:5 dilution treatment at 24 h, (c)
RCSC 1:40 dilution treatment at 24 h. (a’) Control at 72 h, (b’) RCSC 1:5 dilution treatment at 72 h, (c’) RCSC 1:40 dilution treatment at 72 h. Caspase 3/7
staining was observed at 470 nm (10× magnification)
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required for the proliferation and survivability of cancer
cells. It is reported to be expressed at higher levels in
cancer cells, due to alteration of various oncogenes or
due to the overall tumor environment. Due to the hyp-
oxic microenvironment in a rapidly proliferating cancer
cell, LDH is essential to drive the rapid energy require-
ment of the cell through glycolytic metabolism. Glyco-
lytic mechanism even though yields less energy, it
provides energy faster, which is needed for a rapidly
growing tumor cell. LDH converts pyruvate to lactate
with the release of NAD+ that is required for the glyco-
lytic pathway. It also helps in providing substrates for
the synthesis of macromolecules required for the rapidly
growing cell. The lactate produced by LDH has also
been reported to have proliferating and migratory effects
in cancer cells [16]. Various LDH knockdown experi-
ments have been reported to repress tumor progression
[17]. Prominent reduction in LDH due to RCSC may
have halted the metabolism of the cell that resulted in
inhibition of proliferation and possible induction of
apoptosis. This inhibition was reported to occur by p53
dependent or independent pathways [18]. Inhibition of
LDH may have diverted the cell to perform oxidative
phosphorylation to produce energy that leads to exces-
sive production of ROS causing detrimental effects to
the cell. Increase in ROS degrades DNA, macromole-
cules and activates cell death mechanism [19]. This
could be one possible reason as to why we observed cell
death process in RCSC treated cancer cells. The increase
in ROS also has membrane-degrading activities affecting
mitochondrial membrane integrity and trans-membrane
potential resulting in induction of intrinsic pathway of
apoptosis. This is most likely the reason for higher re-
lease of LDH in non-lysed cells. RCSC probably im-
paired cell membrane of lung and colon cancer cell lines
in a dose dependent manner either indirectly through
ROS or directly. Cell membrane is the integral part of
any cell, which helps to maintain homeostasis of the cell
and also regulates many vital characteristics of the cell
such as cell to cell adhesion, metastasis, changes in anti-
genicity and various surface proteins. Release of LDH or
uptake of dyes like PI or trypan blue is a proxy for the
loss of membrane integrity. Loss of membrane integrity
always correlates with loss of viability and has been re-
ported to induce cell death [20]. In the current study,
LDH showed a maximum release at 72 h, which
Fig. 8 Heat map showing expression levels of selected genes in NCI-H460 treated with 1: 40 dilution of RCSC for 72 h. (a) NCI-H460 and (b) MRC-5.
The ΔCt was compared with both their untreated controls. Red color represents upregulation and green color downregulation. Heat map
was generated using Pearson correlation
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correlated with cell mask PM staining of NCI-H460 and
SW620 accompanied with changes in cell membrane
morphology. Cell membranes of cancer cells are always
in a constant stress due to its physiology and the sur-
rounding environment and undergo a continuous repair
through the plasma membrane repair mechanism (PMR)
to maintain and stabilize its integrity [21]. This might be
a possible reason for the decrease in LDH release at
96 h compared to 72 h in cancer cell lines. The other
possibility could be an overall decrease in LDH content
of the cell due to the effect of RCSC as maximum reduc-
tion in total LDH was observed at 96 h. A concentrated
RCSC solution (1:5 dilution) released less LDH than a
diluted RCSC solution (1:80), which can be correlated
with the total reduction of LDH at those particular dilu-
tions. Loss of membrane integrity also explains why PI+
staining was observed on treatment with RCSC.
Early and late signs of apoptotic changes were clearly
observed in fluorescence microscopy indicating the pro-
cesses induced by RCSC. Apoptosis and necrosis are two
different types of cell death that can happen simultan-
eously especially in the early stages. This was observed
at 1:5 dilution treated NCI-H460 at 24 and 72 h. Apop-
tosis is characterized by shrinkage of the cell, nucleus,
and chromatin condensation and finally formation of
apoptotic bodies. Necrosis is characterized by cell swell-
ing with rupture of the membrane and expulsion of the
cell organelles and components. One basic difference be-
tween apoptosis and necrosis is the intact cell membrane
seen in apoptotic cell death, which can be identified by
the PI stain, a red non-permeable stain that only enters
cell when the cell membrane is disintegrated. Under
inverted light microscope, the cell looked pyknotic and
granular suggestive of apoptotic bodies. Another indica-
tor of the apoptotic process is positive caspase 3, 7 stain-
ing. Caspases are a family of enzymes, which are
cysteine aspartic acid proteases mainly involved in the
initiation, and execution of apoptosis. Positive caspase 3
and 7 staining was observed in RCSC treated NCI-H460
indicating activation of caspase 3 and 7, implying that
execution process of apoptosis is in play, which is charac-
terized by cell shrinkage (pyknosis), chromatin condensa-
tion followed by nuclear condensation and fragmentation.
This is followed by phagocytosis by macrophages to
complete the cell death mechanism in vivo [20]. The gene
encoding FASLG protein, which belongs to the tumor ne-
crosis factor superfamily, was upregulated in NCI-H460
treated with RCSC for 72 h. FASLG is involved in the ex-
trinsic pathway of apoptosis and is reported to be induced
by NF-κB cascade. Upregulation of this gene also increases
T cell and cytotoxic T lymphocyte induced cell death [22].
It is possible that the effect on the cell membrane or tar-
geting and reducing LDH may have upregulated FASLG
initiating the apoptotic process.
Gene expression studies identified changes in potential
cancer inhibitory protein encoding genes in RCSC
treated lung cancer cell line, NCI-H460. In comparison,
no such changes were observed in the normal cell line,
MRC-5. Upregulation of genes involved in cell cycle
inhibition, induction of apoptosis either directly or indir-
ectly was observed. Expression of cJUN, a proto-oncogene
which is a component of activator protein (AP1) family
[23] related to the PI3K-AKT and MAPK pathway, was
upregulated. P13K-AKT pathway is an important meta-
bolic pathway modulator of tumor cells. It regulates and
maintains the glycolytic phenotype of tumor cell through
expression of various glycolytic enzymes, cell membrane
glucose transporters, and stimulates other biosynthetic
pathways required for the survival of tumorigenesis [24].
Recently, cJUN was found to have both tumor promotive
and inhibitory effect. Over expression of cJUN was re-
ported in cells arrested in G1 phase of cell cycle. Upregula-
tion of cJUN was reported to downregulate the expression
of various cyclin dependent kinases [23] as it competi-
tively binds to the AP1 site in the cyclin gene promoter.
cJUN has been also reported to induce apoptosis via the
NF-κB-JNK signaling cascade. For example, grape extract
has been reported to induce apoptosis in prostate cancer
cells via Jun N kinase (JNK) signaling and cJUN activation
[25]. JNK signaling is reported to activate cJUN by phos-
phorylation. Another upregulated gene was CDKN1A, a
cyclin-dependent kinase inhibitor needed in maintaining
the progression of the cell cycle. It is regulated by p53, a
tumor suppressor and helps in upregulating the expres-
sion of various antioxidant and detoxifying agents [24].
Another group of genes that showed a significant up-
regulation on RCSC treatment were those encoding in-
tegrin α2 β (ITGA2B) and integrin β3 (ITGB3), which
belong to the cell adhesion molecules of the integrin
family, known to associate with the tyrosine kinase sig-
naling pathways and regulate cell survival, proliferation,
differentiation, adhesion, and migration [26]. They are
known to have cell adhesive properties essential for me-
tastasis. There are various types of integrins, namely,
α26β1, αv β5, α3 β1 whose expression increased in tumor
cells compared to normal cells [27]. An exception to this
pattern is reported for integrin α2 β (ITGA2B) and in-
tegrin β3 (ITGB3). Expression of ITGA2B was reported
to be debilitating to some tumor cells such as breast
cancer cells, which resulted in changing of the malignant
phenotype to normal [28]. Similarly, upregulation of
ITGA2B on treatment with RCSC probably suppressed
NCI-H460 proliferation and survival. ITGB3, on the
other hand, showed apoptosis inducing property in ovar-
ian cancer, gliomas and melanoma [29, 30]. Unligated
integrins form a complex with caspase 8 and activate the
extrinsic pathways of apoptosis [31]. Here, in our in vitro
experiment, integrins were probably involved in
Rahman et al. BMC Complementary and Alternative Medicine  (2016) 16:427 Page 13 of 16
inducing apoptosis since integrins are unligated due to
the absence of a ligating protein of the extracellular
matrices that are present in vivo. These genes showed
no change in expression in normal lung fibroblast,
MRC-5 making RCSC an effective anticancer agent for
lung cancer.
In addition to upregulation of genes, a number of
cancer-promoting genes were downregulated. Downreg-
ulation of cyclin D3 (CCND3) and cyclin dependent kin-
ase (CDK) indicates abrupt halt in cell cycle as the first
line effect of RCSC on NCI-H460 at 24 h. This is sup-
ported by the upregulation of cJUN at 72 h in 1:5 RCSC
treated NCI-H460 which suggests cell cycle arrest. E2F1
maintains a balance between tumor proliferative and
tumor suppressive functions. In cancer cells, the
PI3K-AKT pathway activates E2F1 thereby inactivating
tumor suppressive activity [32]. RCSC treatment leads
to downregulation of E2F1, which is conducive for
anticancer treatment. COL1A1 codes a protein associ-
ated with platelet-derived growth factor (PDGF) sig-
naling pathway, which helps in the maintenance of
tumor stromal and angiogenesis facilitation in metas-
tasis [33]. The downregulation of COL1A1 on RCSC
treatment points to inhibition of cancer cell progres-
sion and possibility of angiogenesis. Cancer migration
or metastasis is a crucial factor in any cancer prognosis. A
metastatic cancer cell has been reported to be highly fatal
with bad prognosis with any cancer treatment. It is im-
portant to note that RCSC is effectively preventing the
metastatic power of the NCI-H460 and thus could serve
as a potent agent in targeting cancer. IGF-1 is a mitogen,
which is usually overexpressed in cancer cells maintaining
cell cycle program regulated by the IGF-1R and help in
transformation and protection of cancer from apoptosis
[34]. IGF-1 was also found to make cancer cells resistant
to apoptosis induced by anti-cancer drugs [35]. In this
context, downregulation of IGF-1 is potentially beneficial
in treating cancer by RCSC alone or in combination with
a known anti-cancer drug.
RCSC treatment upregulated genes that not only help
in cancer promotion by regulating tumor proliferation,
survival, progression, and metastasis but also have tumor
suppressive activities. One such gene was NF-κB2, a
transcription factor, which was upregulated in both 1:5
and 1:40 dilution RCSC treated NCI-H460 at 72 h with
higher expression at 1:40 dilution. In addition to tumor
promoting properties, NF-κB2 has been reported to have
tumor suppressive activities including induction of apop-
tosis, which is mainly mediated by the tumor suppressor
gene, p53 [36]. These cancer suppressive activities of
NF-κB2 is dependent upon the cell type, the type of in-
hibitory stimulus, and the duration of stimulus or signals
[37, 38]. DNA damage was found to activate their tumor
suppressive effect through recruitment and activation of
death receptor inducing the extrinsic pathway of apop-
tosis. It is also possible that the upregulation of NF-κB2
could be a cancer protective mechanism in response to
RCSC treatment. The possible pathway leading to apop-
tosis mediated by RCSC treatment through upregulated
genes in our study, is shown in Fig. 9.
Our final investigation involved studying the effect of
RCSC fractions on LDH content of NCI-H460 at four
time points, which indicated RCSC treatment to be
more effective than its fractionated components. This
supports the hypothesis that a holistic approach of using
the whole RCSC with the synergistic effect of several
compounds is more effective than purified compounds
or fractions. The synergistic effect of multiple com-
pounds is likely to eliminate or minimize the harmful
effects of purified compounds on normal cells.
Fig. 9 Putative pathways involved in inducing apoptosis on RCSC treatment. Proteins regulating apoptosis and encoded by genes upregulated
on RCSC treatment are highlighted in yellow boxes
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Conclusions
RCSC was shown to be superior to Taxol® as it effect-
ively inhibited proliferation of lung and colon cancer
cells with minimal or less effect compared to normal
cells in a dose and time dependent manner. However, it
was less promising with breast cancer cells. A decrease
in the total LDH content in cancer cell lines may have
elicited the upregulation of genes inhibiting cell cycle
and possibly metastatic and angiogenic capability
thereby inducing apoptosis. Further investigation is ne-
cessary to identify the molecular basis of RCSC activity
by using systems biology approach employing gene ex-
pression profiling, proteomics and metabolomics. Unlike
several plant isolated compounds showing potent anti-
cancer effect, RCSC fractions were found to be less ef-
fective than whole RCSC. Further investigations using
other methods for isolation of RCSC compounds
followed by in vitro treatment, can help in arriving at
concrete conclusion. The current study showed positive
results on the potency of RCSC, which have to be con-
firmed in animal models followed by clinical trials. It is
likely that this will lead to the development of a better
drug that is much more efficient with minimal side ef-
fect than the current anticancer drugs.
Additional files
Additional file 1: Figure S1. Total LDH of the colon cancer cell line,
SW620 treated with RCSC. Total LDH in SW620 treated with different
dilutions of rice callus suspension culture for (A) 24 h, (B) 48 h, (C) 72 h,
and (D) 96 h. Cell density used, labeling and statistical significance are as
described for Fig. 1. (JPG 113 kb)
Additional file 2: Figure S2. LDH release from the colon cancer cell
line, SW620 treated with RCSC. Release of LDH due to loss of membrane
integrity of SW620 treated with different dilutions of RCSC for (A) 24 h,
(B) 48 h, (C) 72 h, and (D) 96 h. Cell density used, labeling and statistical
significance are as described for Fig. 1. (JPG 105 kb)
Additional file 3: Figure S3. Cell viability of the colon cancer cell line,
SW620 treated with RCSC. Reduction of cell viability of SW620 treated
with different dilutions of rice callus suspension culture for (A) 24 h, (B)
48 h, (C) 72 h, and (D) 96 h. The y-axis shows average absorbance at
440 nm for WST-1 assay. Cell density used, other labeling and statistical
significance are as described for Fig. 1. (JPG 111 kb)
Additional file 4: Figure S4. Total LDH of the breast cancer cell line,
MDA-MB-231 treated with RCSC. Total LDH in MDA-MB-231 treated with
different dilutions of RCSC for (A) 24 h, (B) 48 h, (C) 72, and (D) 96 h. Cell
density used, labeling and statistical significance are as described for
Fig. 1. (JPG 109 kb)
Additional file 5: Figure S5. LDH release from the breast cancer cell line,
MDA-MB-231 treated with RCSC. Release of LDH due to loss of membrane in-
tegrity of MDA-MB-231 treated with different dilutions of rice callus suspension
culture for (A) 24 h, (B) 48 h, (C) 72 h, and (D) 96 h. Cell density used, labeling
and statistical significance are as described for Fig. 1. (JPG 110 kb)
Additional file 6: Figure S6. LDH release from the breast epithelial cell
line, HMEC treated with RCSC. Release of LDH due to loss of membrane
integrity of HMEC treated with different dilutions of rice callus suspension
culture for (A) 24 h, (B) 48 h, (C) 72, and (D) 96 h. Cell density used, labeling
and statistical significance are as described for Fig. 1. (JPG 107 kb)
Additional file 7: Figure S7. Cell viability of the breast cancer cell line,
MDA-MB-231 treated with RCSC. Reduction of cell viability of MDA-MB-
231 treated with different dilutions of rice callus suspension culture for
(A) 24 h, (B) 48 h, (C) 72 h, and (D) 96 h. The y-axis shows average absorb-
ance at 440 nm for WST-1 assay. Cell density used, other labeling and
statistical significance are as described for Fig. 1. (JPG 109 kb)
Additional file 8: Figure S8. Total LDH of the lung fibroblast cell line,
MRC-5 treated with RCSC. Total LDH of MRC-5 treated with different
dilutions of rice callus suspension culture for (A) 24 h, (B) 48 h, and (C)
72 h, and (D) 96 h. Cell density used, labeling and statistical significance
are as described for Fig. 1. (JPG 115 kb)
Additional file 9: Figure S9. Cell viability of the lung cancer cell line,
A-549 treated with RCSC followed by WST-1 assay. Reduction of cell
viability of A-549 treated with different dilutions of rice callus suspension
culture for (A) 24 h, (B) 48 h, (C) 72 h, and (D) 96 h. The y-axis shows aver-
age absorbance at 440 nm for WST-1 assay. Cell density used, other label-
ing and statistical significance are as described for Fig. 1. (JPG 108 kb)
Additional file 10: Figure S10. Nuclear and plasma membrane
staining of NCI-H460 treated with RCSC. (A & A’) Control (untreated NCI-
H460), (B & B’) Treated with 1:5 dilution RCSC and (C & C’) Treated with
1:40 dilution RCSC for 72 h. A, B and C represent NCI-H460 labeled with
NucBlue live cell stain (365 nm) and A’, B’ and C’ represent cells labeled
with cell mask plasma membrane stain (475 nm) observed at 20× magni-
fication. (JPG 67 kb)
Additional file 11: Figure S11. Nuclear and plasma membrane
staining of SW620 treated with RCSC for 72 h. (A & A’) Control at 72 h. (B
& B’) RCSC 1:5 dilution treatment for 72 h. (C & C’) RCSC 1:40 dilution
treatment for 72 h. SW620 was labeled with NucBlue live cell stain
(365 nm) and cell mask plasma membrane stain (475 nm) and observed
at 20× magnification. (JPG 65 kb)
Additional file 12: Figure S12. Annexin and PI staining of SW620
treated with RCSC. (A) Control (untreated) at 24 h, (B) 1:5 diluted RCSC
treated at 24 h, (C) 1:40 diluted RCSC treated at 24 h. (A’) Control at 72 h,
(B’) 1:5 diluted RCSC treated at 72 h and (C’) 1:40 diluted RCSC treated at
72 h. Annexin and PI stained cells were observed at 365 nm at 20×
magnification. Apoptosis (Annexin+/PI−) was dominant at 72 h in both
1:40 and some 1:5 RCSC dilution treated SW620. 1:40 dilution treated
SW620 at 24 h was mostly PI+. (JPG 29 kb)
Additional file 13: Figure S13. Bar diagram showing quantitative
Caspase 3/7 fluorescence in NCI-H460 after RCSC treatment for 24 h.
Image J analysis was used to quantify fluorescence microscope images
which showed caspase activation in RCSC 1:5 and 1:40 dilution treated NCI-
H460. CTCF represents Corrected Total Cell Fluorescence (n = 5). (PNG 127 kb)
Additional file 14: Figure S14 Bar diagram showing quantitative
Caspase 3/7 fluorescence in NCI-H460 after RCSC treatment for 72 h.
Image analysis and labeling are as described for Additional file 12: Figure
S12. (JPG 34 kb)
Additional file 15: Figure S15. Heat map representing expression
levels of genes associated with cancer in NCI-H460 treated with 1:5
dilution RCSC for 72 h. The ΔCt was compared with untreated control.
The red bar represents upregulation and green downregulation. Heat
map was generated using Pearson correlation. Callus and NCI CM 72 h
represent samples treated with RCSC 1:5 dilution for 24 h and 72 h,
respectively. (JPG 35 kb)
Additional file 16: Figure S16. HPLC chromatogram showing peaks at
254 nm. HPLC fractionation of RCSC showing peak heights on y-axis and
retention time on x-axis. Fractions 1, 2, 3, and 5 selected for treatment of
the lung cancer cell line are shown in the figure. (JPG 51 kb)
Additional file 17: Figure S17. Total LDH absorbance of NCI-H460
treated with RCSC and its HPLC fractions. Total LDH absorbance of NCI-
H460 treated with five HPLC fractions of RCSC and plant media for (A)
24 h, (B) 48 h, (C) 72 h, and (D) 96 h. The x-axis shows different dilutions
of plant media (PM), plant media fractions (PM fr.1, PM fr.2, PM fr. 3, PM
fr.5), RCSC or callus media (CM) and callus media fractions (CM fr.1, CM
fr.2, CM fr. 3, CM fr. 5). The y-axis shows average absorbance at 490 nm of
LDH assay. Error bars represent standard deviation. Statistically significant
effect of different dilutions of callus culture on the viability of cell lines is
indicated by *p < 0.05 and **p < 0.01. Control represents untreated cell
line and Med represents media without cells. (ZIP 185 kb)
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